Bibliographic Info
GuidelineWHO consolidated guidelines on tuberculosis: Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update
Year of Publication2022
Issuing InstitutionWorld Health Organization
Recommendation
Status
Maintained
Recommended in favor
Conditional
Certainty of evidence
Moderate
The following treatment administration options may be offered to patients on TB treatment: a) Community- or home-based treatment support is recommended over health facility-based treatment support or unsupervised treatment
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Year2017
InstitutionWorld Health Organization
Guideline
WHO guidelines on tuberculosis infection prevention and control: 2019 update
Year2019
InstitutionWHO
Guideline
WHO consolidated guidelines on drug-resistant tuberculosis treatment
Year2019
InstitutionWorld Health Organization
Guideline
WHO consolidated guidelines on tuberculosis: Module 4: Treatment - Drug-resistant tuberculosis treatment
Year2020
InstitutionWorld Health Organization
Guideline
WHO consolidated guidelines on tuberculosis: module 4: treatment and care
Year2025
InstitutionWorld Health Organization